Cargando…
Thioredoxin-interacting protein: A new therapeutic target in bone metabolism disorders?
Target identification is essential for developing novel therapeutic strategies in diseases. Thioredoxin-interacting protein (TXNIP), also known as thioredoxin-binding protein-2, is a member of the α-arrestin protein family and is regulated by several cellular stress factors. TXNIP overexpression cou...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428757/ https://www.ncbi.nlm.nih.gov/pubmed/36059548 http://dx.doi.org/10.3389/fimmu.2022.955128 |